ATE507720T1 - Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands - Google Patents
Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustandsInfo
- Publication number
- ATE507720T1 ATE507720T1 AT06825270T AT06825270T ATE507720T1 AT E507720 T1 ATE507720 T1 AT E507720T1 AT 06825270 T AT06825270 T AT 06825270T AT 06825270 T AT06825270 T AT 06825270T AT E507720 T1 ATE507720 T1 AT E507720T1
- Authority
- AT
- Austria
- Prior art keywords
- prognosis
- diagnosis
- lysophosphatidylcholine
- inflammatory condition
- detection
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 230000004968 inflammatory condition Effects 0.000 title abstract 2
- 238000004393 prognosis Methods 0.000 title abstract 2
- 230000009885 systemic effect Effects 0.000 title abstract 2
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 206010040047 Sepsis Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72183305P | 2005-09-28 | 2005-09-28 | |
| US76291106P | 2006-01-27 | 2006-01-27 | |
| US84140706P | 2006-08-30 | 2006-08-30 | |
| PCT/US2006/038177 WO2007038758A2 (en) | 2005-09-28 | 2006-09-27 | Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE507720T1 true ATE507720T1 (de) | 2011-05-15 |
Family
ID=37900497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06825270T ATE507720T1 (de) | 2005-09-28 | 2006-09-27 | Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8183050B2 (de) |
| EP (1) | EP1940231B1 (de) |
| JP (1) | JP5183480B2 (de) |
| KR (1) | KR101281298B1 (de) |
| AT (1) | ATE507720T1 (de) |
| AU (1) | AU2006294481B2 (de) |
| BR (1) | BRPI0616720A2 (de) |
| CA (1) | CA2623523C (de) |
| DE (1) | DE602006021768D1 (de) |
| WO (1) | WO2007038758A2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080006617A (ko) | 2005-04-15 | 2008-01-16 | 백톤 디킨슨 앤드 컴퍼니 | 패혈증의 진단 |
| EP1940231B1 (de) | 2005-09-28 | 2011-05-04 | Becton, Dickinson & Company | Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands |
| US20090104605A1 (en) * | 2006-12-14 | 2009-04-23 | Gary Siuzdak | Diagnosis of sepsis |
| JP5357871B2 (ja) * | 2007-07-13 | 2013-12-04 | コーニンクレッカ フィリップス エヌ ヴェ | 急性の動的な疾患の意思決定支援システム |
| US9213030B2 (en) * | 2008-01-28 | 2015-12-15 | National University Of Singapore | Lipid tumour profile |
| US20090234202A1 (en) * | 2008-03-05 | 2009-09-17 | Goix Philippe J | Method and compositions for highly sensitive detection of molecules |
| US8669113B2 (en) | 2008-04-03 | 2014-03-11 | Becton, Dickinson And Company | Advanced detection of sepsis |
| CN102388304B (zh) | 2009-04-10 | 2014-03-12 | 佳能株式会社 | 形成质量图像的方法 |
| AU2010259022B2 (en) | 2009-06-08 | 2016-05-12 | Singulex, Inc. | Highly sensitive biomarker panels |
| US8600556B2 (en) * | 2009-06-22 | 2013-12-03 | Johnson Controls Technology Company | Smart building manager |
| US8417541B1 (en) * | 2009-08-27 | 2013-04-09 | Cerner Innovation, Inc. | Multi-stage model for predicting probabilities of mortality in adult critically ill patients |
| EP2339352A1 (de) | 2009-12-28 | 2011-06-29 | BIOCRATES Life Sciences AG | Verwendung endogener Metaboliten zur frühen Sepsiserkennung |
| ITRM20100121A1 (it) * | 2010-03-18 | 2011-09-19 | Univ Pisa | Marcatori molecolari per infezioni delle vie urinarie. |
| DK2385374T4 (en) * | 2010-05-05 | 2018-04-30 | Zora Biosciences Oy | LIPIDOMICS BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE |
| US20110301053A1 (en) | 2010-05-06 | 2011-12-08 | Singulex, Inc. | Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis |
| US8904511B1 (en) * | 2010-08-23 | 2014-12-02 | Amazon Technologies, Inc. | Virtual firewalls for multi-tenant distributed services |
| US9336302B1 (en) | 2012-07-20 | 2016-05-10 | Zuci Realty Llc | Insight and algorithmic clustering for automated synthesis |
| US20150285805A1 (en) | 2012-11-05 | 2015-10-08 | Ospedale San Raffaele S.R.L. | Biomarkers of multiple myeloma development and progression |
| WO2014150329A1 (en) * | 2013-03-14 | 2014-09-25 | University Of Georgia Research Foundation, Inc. | Lipid biomarkers of addiction and relapse risk |
| CN104458708A (zh) * | 2013-09-12 | 2015-03-25 | 中国药科大学 | 一种筛选乙酰胆碱酯酶抑制剂高通量筛选方法 |
| US10260111B1 (en) | 2014-01-20 | 2019-04-16 | Brett Eric Etchebarne | Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample |
| JP2019511057A (ja) * | 2016-03-23 | 2019-04-18 | ピーチ インテリヘルス，インコーポレイティド | Ｓｉｒｓの予測のための臨床パラメータの使用 |
| US11205103B2 (en) | 2016-12-09 | 2021-12-21 | The Research Foundation for the State University | Semisupervised autoencoder for sentiment analysis |
| WO2019131578A1 (ja) * | 2017-12-26 | 2019-07-04 | 民男 山内 | 免疫動態に関する情報を提供する方法、システムおよびプログラム |
| WO2020137172A1 (ja) * | 2018-12-27 | 2020-07-02 | 公立大学法人奈良県立医科大学 | 間質性膀胱炎の診断方法 |
| US20220146527A1 (en) * | 2019-09-17 | 2022-05-12 | Chang Gung University | Method of creating characteristic profiles of mass spectra and identification model for analyzing and identifying features of microorganisms |
| KR102259533B1 (ko) | 2021-01-04 | 2021-06-02 | 주식회사 아리바이오 | Lpc와 pct를 조합하는 패혈증 진단용 바이오마커 조성물 및 이를 이용한 진단방법 |
| CN113189115B (zh) * | 2021-05-17 | 2022-07-08 | 中国矿业大学 | 一种温度场测量及焊接缺陷在线监测装置及监测方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (de) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimäre Rezeptoren durch Verbindung und Expression von DNS |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| AU8507191A (en) | 1990-08-29 | 1992-03-30 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| JPH05229993A (ja) | 1991-12-13 | 1993-09-07 | Fujirebio Inc | トリフェニルメタン誘導体 |
| US6190872B1 (en) | 1994-05-06 | 2001-02-20 | Gus J. Slotman | Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method |
| JP3436444B2 (ja) * | 1995-07-21 | 2003-08-11 | ヤマサ醤油株式会社 | 酸化ｈｄｌの測定法及びキット |
| US6248553B1 (en) * | 1998-10-22 | 2001-06-19 | Atairgin Technologies, Inc. | Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids |
| JP2002017938A (ja) | 2000-07-07 | 2002-01-22 | Toyo Kogyo Kk | 脛当て |
| US7465555B2 (en) | 2002-04-02 | 2008-12-16 | Becton, Dickinson And Company | Early detection of sepsis |
| US7015022B2 (en) * | 2002-06-07 | 2006-03-21 | University Of Medicine & Dentistry Of New Jersey | Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities |
| MXPA05005071A (es) | 2002-11-12 | 2005-07-22 | Becton Dickinson Co | Diagnostico de la sepsis o sirs usando perfiles de biomarcadores. |
| BR0316232A (pt) | 2002-11-12 | 2005-10-04 | Becton Dickinson Co | Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo |
| EP1573054A4 (de) | 2002-11-12 | 2005-12-28 | Becton Dickinson Co | Sepsis- oder sirs-diagnose mittels biomarkerprofilen |
| WO2005034952A2 (en) | 2003-10-07 | 2005-04-21 | The Feinstein Institute For Medical Research | Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| EP1940231B1 (de) | 2005-09-28 | 2011-05-04 | Becton, Dickinson & Company | Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands |
| US8669113B2 (en) | 2008-04-03 | 2014-03-11 | Becton, Dickinson And Company | Advanced detection of sepsis |
-
2006
- 2006-09-27 EP EP06825270A patent/EP1940231B1/de active Active
- 2006-09-27 JP JP2008533696A patent/JP5183480B2/ja active Active
- 2006-09-27 WO PCT/US2006/038177 patent/WO2007038758A2/en not_active Ceased
- 2006-09-27 AT AT06825270T patent/ATE507720T1/de not_active IP Right Cessation
- 2006-09-27 CA CA2623523A patent/CA2623523C/en active Active
- 2006-09-27 DE DE602006021768T patent/DE602006021768D1/de active Active
- 2006-09-27 AU AU2006294481A patent/AU2006294481B2/en active Active
- 2006-09-27 BR BRPI0616720-9A patent/BRPI0616720A2/pt not_active Application Discontinuation
- 2006-09-27 KR KR1020087010053A patent/KR101281298B1/ko active Active
- 2006-09-28 US US11/541,412 patent/US8183050B2/en active Active
-
2012
- 2012-04-18 US US13/450,228 patent/US20120301910A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR101281298B1 (ko) | 2013-07-08 |
| EP1940231A4 (de) | 2008-12-31 |
| WO2007038758A3 (en) | 2007-09-13 |
| BRPI0616720A2 (pt) | 2011-06-28 |
| WO2007038758A2 (en) | 2007-04-05 |
| EP1940231B1 (de) | 2011-05-04 |
| JP2009510450A (ja) | 2009-03-12 |
| EP1940231A2 (de) | 2008-07-09 |
| KR20080068824A (ko) | 2008-07-24 |
| US20070111316A1 (en) | 2007-05-17 |
| US8183050B2 (en) | 2012-05-22 |
| DE602006021768D1 (de) | 2011-06-16 |
| AU2006294481B2 (en) | 2012-12-20 |
| US20120301910A1 (en) | 2012-11-29 |
| JP5183480B2 (ja) | 2013-04-17 |
| CA2623523C (en) | 2019-02-12 |
| CA2623523A1 (en) | 2007-04-05 |
| AU2006294481A1 (en) | 2007-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006021768D1 (de) | Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands | |
| CY1117784T1 (el) | Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας | |
| DE602005020997D1 (de) | Verfahrenshilfsmittel für elastomerzusammensetzungen | |
| CY1111839T1 (el) | Μεθοδος για την διαγνωση της πολλαπλης σκληρυνσης | |
| WO2010148391A3 (en) | Biomarker assay of neurological condition | |
| ATE511030T1 (de) | Mehrteiliger axialkäfig für ein grosswälzlager | |
| ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
| ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
| WO2009114756A3 (en) | Biomarkers for inflammatory bowel disease and irritable bowel syndrome | |
| ATA13292004A (de) | Aluminiumlegierung für tribologisch beanspruchte flächen | |
| PT2129391E (pt) | Método de diagnóstico | |
| WO2009006347A3 (en) | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes | |
| MX2012001559A (es) | Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal. | |
| DE602006010956D1 (de) | Magnetische Partikel für die Diagnostik | |
| NZ601648A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| DK1864129T3 (da) | Doxurubicin-immunassay | |
| BRPI0606685A2 (pt) | anticorpos gitr para o diagnóstico de nsclc | |
| AU2010209763A8 (en) | Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof | |
| WO2009141679A3 (en) | Ceacam1 based point-of-care cancer diagnostic | |
| WO2008149364A3 (en) | Methods for diagnosing hypersensitivity reactions | |
| WO2006091861A3 (en) | Compositions and methods relating to cns lymphoma | |
| ATE440937T1 (de) | Flüssiges reinigungsmittel für feste oberflächen | |
| DE602006005182D1 (de) | Wälzlager für Hilfsaggregate von Kraftfahrzeugen mit der Fähigkeit Abblättern durch Verspröden zu verhindern | |
| ATE504598T1 (de) | Cspcna-isoform-modifikationen und anwendungen davon | |
| TW200801015A (en) | Substituted aminophenylsulfonamide compounds as HIV protease inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |